Interferon Beta-1a (AVONEX^®) as a Treatment Option for Untreated Patients with Multiple Sclerosis (AXIOM): A Prospective, Observational Study

By Kleinschnitz Christoph   Niemczyk Gabriele   Rehberg-Weber Karin   Wernsdörfer Colin  

International Journal of Molecular Sciences, Vol. 16, Iss. 7, 2015-07 ,pp. : 15271-15286

MDPI

Access to resources Recommend Favorite

MicroRNA Expression Changes during Interferon-Beta Treatment in the Peripheral Blood of Multiple Sclerosis Patients

By Hecker Michael   Thamilarasan Madhan   Koczan Dirk   Schröder Ina   Flechtner Kristin   Freiesleben Sherry   Füllen Georg   Thiesen Hans-Jürgen   Zettl Uwe Klaus  

International Journal of Molecular Sciences, Vol. 14, Iss. 8, 2013-08 ,pp. : 16087-16110

MDPI

Access to resources Recommend Favorite

Multiple Sclerosis: From Molecules to Treatment

By Broadley Simon A  

International Journal of Molecular Sciences, Vol. 14, Iss. 4, 2013-04 ,pp. : 7598-7602

MDPI

Access to resources Recommend Favorite

Interferon-β1b Increases Th2 Response in Neuromyelitis Optica

By Nakajima Hideto   Hosokawa Takafumi   Doi Yoshimitu   Ikemoto Toshiyuki   Ishida Shimon   Kimura Fumiharu   Hanafusa Toshiaki  

International Journal of Molecular Sciences, Vol. 13, Iss. 10, 2012-09 ,pp. : 12213-12223

MDPI

Access to resources Recommend Favorite

Polymorphismsof the CD24 Gene Are Associated with Risk of Multiple Sclerosis: A Meta-Analysis

By Braliou Georgia G.   Pantavou Katerina G.   Kontou Panagiota I.   Bagos Pantelis G.  

International Journal of Molecular Sciences, Vol. 16, Iss. 6, 2015-06 ,pp. : 12368-12381

MDPI

Access to resources Recommend Favorite